Doxanano is committed to pushing the limits of conventional chemotherapy for patients with solid tumors. Our goal is to significantly increase the selective delivery of chemotherapeutic agents into the tumor whilst dramatically limiting adverse effects on healthy organs. We specialize in harnessing the unique properties of our DXN polymersomes drug delivery platform in combination with the precision of radiotherapy.
| Website | https://doxanano.com/ |
| Employees | 9 (4 on RocketReach) |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Cancer Treatment, Oncolytic Viruses, Chemotherapy, Drug Delivery, Immunotherapy, Solid Tumors, Targeted Therapy, Cancer Therapies, Oncology, Cancer Research, Clinical Trials, Pharmaceutical, Biotechnology, Medical Technology, Precision Medicine, Tumor Targeting, Therapeutic Agents, Drug Development, Cancer Drugs |
Looking for a particular Doxanano employee's phone or email?
Doxanano Questions
Leslie Dubrana is the Co-founder and Scientific Partnership Officer of Doxanano.
4 people are employed at Doxanano.
Top Doxanano Employees
G2Crowd Trusted
300K+
Plugin Users
